Management of COVID-19 vaccines cold chain logistics: a scoping review

References

• ArnoldC. The biggest logistics challenge in history. New Scientist. 2020;248(3309):36–40.
   Google Scholar
• WoutersOJ,ShadlenKC,Salcher-KonradM,PollardAJ,LarsonHJ,TeerawattananonY,et al. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023–1034.
   PubMed Web of Science ®Google Scholar
• Malaysian Health Technology Assessment S. COVID-19 Vaccine: Based on available evidence up to 16 November 2020. 2020.
   Google Scholar
• HaleT,AngristN,GoldszmidtR,KiraB,PetherickA,PhillipsT,et al. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nat Hum Behav. 2021;5(4):529–538.
   PubMed Web of Science ®Google Scholar
• LooK-Y,LetchumananV. COVID-19: Malaysia’s fight against this deadly virus. Progr Microb Mol Biol. 2021;4:1.
   Google Scholar
• COVID-19 Immunisation Task Force : Ministry of Health Malaysia; 2021 https://covidnow.moh.gov.my.
   Google Scholar
• National Pharmaceutical Control Bureau N. Supplementary Notes for Management of Cold Chain Products / Materials Chapter 15 Guidelines on Good Distribution Practice (GDP). 2015. p. 47.
   Google Scholar
• Ganasegeran K, Ch’ng ASH, Looi I. What Is the Estimated COVID-19 Reproduction Number and the Proportion of the Population That Needs to Be Immunized to Achieve Herd Immunity in Malaysia? A Mathematical Epidemiology Synthesis. COVID. 2021;1(1):13–9.
   Google Scholar
• HolmMR,PolandGA. Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy. Vaccine. 2021;39(3):457–459.
   PubMed Web of Science ®Google Scholar
• GrauS,FerrándezO,Martín-GarcíaE,MaldonadoR. Accidental Interruption of the Cold Chain for the Preservation of the Moderna COVID-19 Vaccine. Vaccines (Basel). 2021;9(5):512.
   PubMed Web of Science ®Google Scholar
• Training for mid-level managers (MLM). Module 1: cold chain, vaccines and safe-injection equipment management. Geneva: World Health Organization; 2008, republished 2020 under the licence: CC BY-NC-SA 3.0 IGO. 2020.
   Google Scholar
• YuYB,BriggsKT,TarabanMB,BrinsonRG,MarinoJP. Grand challenges in pharmaceutical research series: ridding the cold chain for biologics. Pharm Res. 2021;38(1):3–7.
   PubMed Web of Science ®Google Scholar
• Rashid M. The Humanitarian Logistics and Supply Chain Research Institute Hanken School of Economics Helsinki. Identify constraints of vaccine supply chain: A Case study of Finnish Red Cross 2020.
   Google Scholar
• NguyenA,LamouriS,PellerinR,TamayoS,LekensB. Data analytics in pharmaceutical supply chains: state of the art, opportunities, and challenges. Int J Prod Res. 2021;1:1–20.
   Google Scholar
• LinQ,ZhaoQ,LevB. Cold chain transportation decision in the vaccine supply chain. Eur J Oper Res. 2020;283(1):182–195.
   Web of Science ®Google Scholar
• Pufahl L, Ihde S, Stiehle F, Weske M, Weber I. Automatic Resource Allocation in Business Processes: A Systematic Literature Survey. 2021.
   Google Scholar
• Wolicki J. Vaccine storage and handling; Vaccine administration–2020. Centers for Disease Control and Prevention. 2020.
   Google Scholar
• RamakanthD,SinghS,MajiPK,LeeYS,GaikwadKK. Advanced packaging for distribution and storage of COVID-19 vaccines: a review. Environ Chem Lett. 2021;1:1–12.
   Google Scholar
• Pfizer. Pfizer And Biontech Submit Covid-19 Vaccine Stability Data At Standard Freezer Temperature To The U.S. Fda: Pfizer; 2021 [updated February 19, 2021. February 19, 2021].
   Google Scholar
• Moderna. First Participants Dosed in Phase 1 Study Evaluating mRNA-1283, Moderna’s Next Generation COVID-19 Vaccine: Moderna; 2021 https://investors.modernatx.com/news-releases/news-release-details/first-participants-dosed-phase-1-study-evaluating-mrna-1283.
   Google Scholar
• Termini RB. An Essay on Public Health and Liberty-The Impact of the 1905 United States Supreme Court Decision of Jacobson: Compulsory Vaccination under State Police Power vs. the Individual Right to Refuse a Vaccination in this Modern-Day Era of the COVID-19 Pandemic. Widener Law Review, Forthcoming. 2021.
   Google Scholar
• de BoeckK,DecouttereC,VandaeleN. Vaccine distribution chains in low-and middle-income countries: a literature review. Omega. 2020;97:102097.
   Web of Science ®Google Scholar
• DadariIK,ZgiborJC. How the use of vaccines outside the cold chain or in controlled temperature chain contributes to improving immunization coverage in low-and middle-income countries (LMICs): a scoping review of the literature. Journal of Global Health. 2021;11:1.
   Web of Science ®Google Scholar
• Asaturova Y, Kochman A, editors. Innovative Activity as a key Factor in the Formation of Innovative Potential of Enterprises. ECIE 2020 16th European Conference on Innovation and Entrepreneurship; 2020: Academic Conferences limited.
   Google Scholar
• Abbasi B, Fadaki M, Kokshagina O, Saeed N, Chhetri P. Modeling vaccine allocations in the covid-19 pandemic: A case study in australia. Available at SSRN 3744520. 2020.
   Google Scholar
• MohammedSA,WorknehBD. Vaccine Cold chain management in public health facilities of oromia special zone, Amhara Region, Ethiopia: Mixed Study. J Drug Alcohol Res. 2021;10(8):1–9.
   Google Scholar
• AlamST,AhmedS,AliSM,SarkerS,KabirG,Ul-IslamA. Challenges to COVID-19 vaccine supply chain: implications for sustainable development goals. Int J Prod Econ. 2021;239:108193.
   PubMed Web of Science ®Google Scholar
• SunJ,ZhangM,GehlA,FrickeB,NawazK,GluesenkampK,et al. COVID 19 vaccine distribution solution to the last mile challenge: experimental and simulation studies of ultra-low temperature refrigeration system. Int J Refrig. 2022;133:313–325.
   PubMedGoogle Scholar
• Nadimuthu LPR, Victor K. Environmental friendly micro cold storage for last-mile Covid-19 vaccine logistics. Environ Sci Pollut Res. 2021.
   Google Scholar
• ShrettaR,HupertN,OseweP,WhiteLJ. Vaccinating the world against COVID-19: getting the delivery right is the greatest challenge. BMJ Glob Health. 2021;6(3):10–12.
   Web of Science ®Google Scholar
• KumarVM,Pandi-PerumalSR,TrakhtI,ThyagarajanSP. Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases. NPJ Vaccines. 2021;6:1.
   PubMed Web of Science ®Google Scholar
• YongB,ShenJ,LiuX,LiF,ChenH,ZhouQ. An intelligent blockchain-based system for safe vaccine supply and supervision. Int J Inform Manag. 2020;52:102024.
   Web of Science ®Google Scholar
• SchroederM,LodemannS. A systematic investigation of the integration of machine learning into supply chain risk management. Logistics. 2021;5(3):62.
   Google Scholar
• KartogluUH,MooreKL,LloydJS. Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers. Vaccine. 2020;38(34):5393–5395.
   PubMed Web of Science ®Google Scholar
• CrommelinDJA,AnchordoquyTJ,VolkinDB,JiskootW,MastrobattistaE. Addressing the cold reality of mrna vaccine stability. J Pharm Sci. 2021;110(3):997–1001.
   PubMed Web of Science ®Google Scholar
• AboulFotouhK,CuiZ,WilliamsRO. Next-Generation COVID-19 vaccines should take efficiency of distribution into consideration. AAPS PharmSciTech. 2021;22:3.
   Web of Science ®Google Scholar
• ExclerJ-L,Privor-DummL,KimJH. Supply and delivery of vaccines for global health. Curr Opin Immunol. 2021;71:13–20.
   PubMed Web of Science ®Google Scholar